Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Finished Goods (2012 - 2015)

Updated

Grace Therapeutics' Finished Goods was $37,705 in fiscal Q4 2015 (quarter ended Feb 28, 2015), compared with $1,874 a year earlier.

Analysis

Grace Therapeutics (GRCE) Finished Goods (2012 - 2015) Analysis & Trends

From fiscal Q4 2012 onward, Grace Therapeutics has reported Finished Goods for 4 quarters.

  • Finished Goods shows a three-year compound annual growth rate of -45.3% (FY2012 to FY2015).
  • In earlier fiscal years, Finished Goods was $2,085 in FY2014 (-98.8%), $176,320 in FY2013 (-23.4%) and $230,128 in FY2012.
  • The fiscal Q4 2015 figure marks the highest quarterly Finished Goods since fiscal Q4 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Feb 28, 2015 37,705.35
Feb 28, 2014 1,874.49
Feb 28, 2013 172,280.03
Feb 29, 2012 230,128.00
API Access

Grace Therapeutics Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=GRCE&period=max&api_key=YOUR_API_KEY